Follow the EMPULSE: In-hospital initiation of empagliflozin for heart failure across the spectrum of left ventricular ejection fraction

Eur J Heart Fail. 2024 Apr;26(4):971-973. doi: 10.1002/ejhf.3256. Epub 2024 Apr 23.

Authors

Tann Lien^#¹, Kishan Srikanth^#¹, Andrew P Ambrosy^{2

3}

Affiliations

¹ Department of Medicine, Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.
² Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.
³ Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.

^# Contributed equally.

PMID: 38654440
DOI: 10.1002/ejhf.3256

No abstract available

Publication types

Letter
Editorial

MeSH terms

Benzhydryl Compounds* / therapeutic use
Female
Glucosides* / therapeutic use
Heart Failure* / drug therapy
Heart Failure* / physiopathology
Hospitalization
Humans
Male
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
Stroke Volume* / physiology
Ventricular Function, Left / drug effects
Ventricular Function, Left / physiology

Substances

Glucosides
Benzhydryl Compounds
empagliflozin
Sodium-Glucose Transporter 2 Inhibitors